Trevi Therapeutics, Inc. (TRVI) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-04

Trevi Therapeutics, Inc. (TRVI) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-04. 2 Form 8-K material event filings were reported by TRVI in the last 90 days. InsiderAlpha tracks every TRVI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Trevi Therapeutics, Inc. (TRVI)

SEC CIK	0001563880

90-Day SEC Filing Activity

Form 4 filings (90d)	5
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-06-04

Recent TRVI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-12-02	Galletta Christopher	See Remarks	M — Option exercise	4.2K	$0.51	$2K	SEC
2024-12-13	Galletta Christopher	See Remarks	M — Option exercise	15.0K	$0.51	$8K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Trevi Therapeutics, Inc. (TRVI). Updated in real time as new filings are submitted to the SEC.

Most-Active TRVI Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Mathers Edward T	1	—
Heffernan Michael Thomas	1	—
VANLENT ANNE	1	—
Colangelo Dominick	1	—
Meeker David P	1	—

Recent TRVI Form 8-K Material Events

2026-06-04 — Item 5.03, 5.07, 9.01 [SEC]
2026-05-05 — Item 2.02, 9.01 [SEC]
2026-04-17 — Item 1.01, 2.02, 8.01, 9.01 · Financing · positive [SEC]
Trevi Therapeutics entered into an underwriting agreement to conduct an underwritten secondary offering of 11.6 million shares at $13.00 per share, with an additional 1.74 million share option for underwriters. The company expects to raise approximately $141.1 million in net proc
2026-03-17 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Trevi Therapeutics announced its financial results for the quarter and year ended December 31, 2025 on March 17, 2026. The filing provides standard financial reporting without explicit beat/miss language or forward guidance changes.
2026-03-09 — Item 8.01 [SEC]

Recent Insider Filings

2026-06-04 — Mathers Edward T (Insider)
2026-06-04 — Colangelo Dominick (Insider)
2026-06-04 — Meeker David P (Insider)
2026-06-04 — VANLENT ANNE (Insider)
2026-06-04 — Heffernan Michael Thomas (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TRVI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

TRVI Insider Trading — FAQ

What is the latest insider trade for TRVI?: Trevi Therapeutics, Inc. (TRVI) had 5 insider filings in the last 90 days, with the most recent on 2026-06-04. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying TRVI stock?: 0 insider purchases of TRVI were filed in the last 90 days.
How many insiders are selling TRVI stock?: 0 insider sales of TRVI were filed in the last 90 days.
Where can I see TRVI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every TRVI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live TRVI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.